Ensuring Informed CML Care from Diagnosis Onward

Opinion
Video

Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following:

  • As patients progress through their CML journey, how does the focus of shared decision-making evolve between the patient, caregiver, and healthcare team? What are some of the key challenges or changes you've observed in the patient, physician, and caregiver role over time?
    • What advice would you direct to patients and caregivers in navigating these changes?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The medical characteristics of a patient may heavily factor into the selection of tyrosine kinase inhibition for the treatment of chronic myeloid leukemia.
The toxicity profile of interferon and the limited availability of transplantation established a need for TKI development for chronic myeloid leukemia.
4 experts in this video